Inozyme Pharma | ARS:年度報告
04/26 16:46 (美東)
Inozyme Pharma | DEFA14A:其他
04/26 16:45 (美東)
Inozyme Pharma | DEF 14A:股東委託書決議
04/26 16:42 (美東)
Inozyme Pharma | 8-K:重大事件
04/08 06:47 (美東)
Inozyme Pharma | 4:持股變動聲明-高管 Treco Douglas A
04/03 17:30 (美東)
Inozyme Pharma | 4:持股變動聲明-高管 Winton Matthew
04/03 17:26 (美東)
Inozyme Pharma | 4:持股變動聲明-高管 Winton Matthew
03/15 08:35 (美東)
Inozyme Pharma | 4:持股變動聲明-高管 Treco Douglas A
03/15 08:35 (美東)
Inozyme Pharma | 4:持股變動聲明-高管 Subramanian Sanjay
03/15 08:35 (美東)
Inozyme Pharma | S-8:員工福利計劃證券登記
03/12 08:42 (美東)
Inozyme Pharma | 10-K:年度報表
03/12 08:37 (美東)
Inozyme Pharma | 8-K:重大事件
03/12 08:37 (美東)
Inozyme Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%)等
02/20 19:14 (美東)
Inozyme Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%)等
02/14 20:38 (美東)
Inozyme Pharma | SC 13G/A:超過5%持股股東披露文件(修正)
02/14 18:13 (美東)
Inozyme Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(0.0%),Baker Bros. Advisors (GP) LLC(0.0%)等
02/14 17:49 (美東)
Inozyme Pharma | SC 13G:超過5%持股股東披露文件-Samlyn Capital, LLC(5.5%),Samlyn, LP(5.5%)等
02/14 16:00 (美東)
Inozyme Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-Rock Springs Capital Management LP(5.96%),Rock Springs Capital LLC(5.96%)等
02/14 14:13 (美東)
Inozyme Pharma | SC 13G:超過5%持股股東披露文件-Eventide Asset Management, LLC(5.15%),Finny Kuruvilla, M.D. Ph. D.(5.15%)等
02/14 11:57 (美東)
Inozyme Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%)等
02/14 08:52 (美東)
暫無數據
暫無數據